Trial Profile
Randomized controlled trial of efficacy of mosapride plus omeprazole versus omeprazole alone in therapy of gastroesophageal reflux disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 May 2012
Price :
$35
*
At a glance
- Drugs Mosapride (Primary) ; Omeprazole
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 22 May 2012 Results presented at the Digestive Disease Week 2012.
- 19 May 2011 Primary endpoint 'Frequency-Scale-for-Symptoms-of-GERD' has not been met.
- 29 Dec 2010 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.